ETON PHARMACEUTICALS INC (ETON) Stock Earnings & Estimates
NASDAQ:ETON - US29772L1089 - Common Stock
17.67 USD
-0.2 (-1.12%)
17.67 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.25M -2.66% | 31.642M 48.90% | 39.011M 23.29% | 80.071M 105.25% | 112.77M 40.84% | 146.92M 30.28% | 196.25M 33.58% | 229.66M 17.02% | 260.56M 13.45% | 389.99M 49.67% | 434.85M 11.50% | |
| EBITDA YoY % growth | -6.98M -571.15% | -291K 95.83% | -1.036M -256.01% | 20.094M 2,039.58% | 41.208M 105.08% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.75M -483.33% | -1.192M 86.38% | -2.182M -83.05% | 8.266M 478.83% | 33.968M 310.94% | 57.037M 67.91% | 92.297M 61.82% | 115.48M 25.12% | 136.83M 18.49% | 234.13M 71.11% | 269.1M 14.94% | |
| Operating Margin | -41.18% | -3.77% | -5.59% | 10.32% | 30.12% | 38.82% | 47.03% | 50.28% | 52.51% | 60.03% | 61.88% | |
| EPS YoY % growth | -0.35 -218.18% | -0.06 82.86% | -0.14 -133.33% | 0.18 228.72% | 1.05 483.01% | 1.55 47.90% | 2.30 47.70% | 2.56 11.56% | 2.77 8.37% | 5.70 105.51% | 6.52 14.31% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.09 206.00% | 0.23 1,273.00% | 0.17 147.71% | 0.24 339.70% | 0.29 216.67% | 0.36 52.17% | 0.21 23.53% | 0.28 14.89% | 0.32 8.77% | 0.36 |
| Revenue Q2Q % growth | 20.883M 102.28% | 22.257M 91.10% | 24.622M 42.47% | 27.811M 46.93% | 30.056M 43.93% | 33.068M 48.57% | 28.254M 14.75% | 32.334M 16.26% | 33.456M 11.31% | 35.496M 7.34% |
| EBITDA Q2Q % growth | 6.222M 378.62% | 7.548M 244.66% | 7.752M 1,327.62% | 9.894M 1,722.10% | 10.812M 73.77% | 12.036M 59.46% | 11.628M 50.00% | 13.974M 41.24% | 15.402M 42.45% | 17.034M 41.53% |
| EBIT Q2Q % growth | 3.282M 544.79% | 6.986M 569.16% | 5.989M 1,374.26% | 8.009M 642.98% | 9.685M 195.09% | 11.694M 67.39% | 8.466M 41.36% | 10.812M 35.00% | 12.24M 26.38% | 13.872M 18.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.10 16.67% | -0.04 | -0.06 | -167.36% |
| Q1 2025 Q2Q % growth | 0.07 333.33% | 0.05 | 0.02 | 28.68% |
| Q4 2024 Q2Q % growth | -0.02 77.78% | 0.00 | -0.02 | -488.82% |
| Q3 2024 Q2Q % growth | 0.03 250.00% | -0.01 | 0.04 | 394.12% |
| Q2 2024 Q2Q % growth | -0.12 -180.00% | -0.07 | -0.05 | -68.07% |
| Q1 2024 Q2Q % growth | -0.03 70.00% | -0.05 | 0.02 | 34.64% |
| Q4 2023 Q2Q % growth | -0.09 -325.00% | -0.04 | -0.05 | -120.59% |
| Q3 2023 Q2Q % growth | -0.02 83.33% | -0.10 | 0.08 | 80.39% |
| Q2 2023 Q2Q % growth | 0.15 350.00% | -0.09 | 0.24 | 263.40% |
| Q1 2023 Q2Q % growth | -0.10 52.38% | -0.14 | 0.04 | 29.97% |
| Q4 2022 Q2Q % growth | 0.04 | 0.01 | 0.03 | 292.16% |
| Q3 2022 Q2Q % growth | -0.12 50.00% | -0.15 | 0.03 | 21.57% |
| Q2 2022 Q2Q % growth | -0.06 40.00% | 0.03 | -0.09 | -296.08% |
| Q1 2022 Q2Q % growth | -0.21 -210.53% | -0.08 | -0.13 | -157.35% |
| Q4 2021 Q2Q % growth | 0.04 112.50% | 0.19 | -0.15 | -79.36% |
| Q3 2021 Q2Q % growth | -0.24 22.58% | -0.14 | -0.10 | -74.29% |
| Q2 2021 Q2Q % growth | -0.10 56.52% | -0.14 | 0.04 | 29.97% |
| Q1 2021 Q2Q % growth | 0.19 138.00% | 0.19 | 0.00 | -1.96% |
| Q4 2020 Q2Q % growth | -0.32 -113.33% | -0.27 | -0.05 | -20.66% |
| Q3 2020 Q2Q % growth | -0.31 -10.71% | -0.26 | -0.05 | -19.97% |
| Q2 2020 Q2Q % growth | -0.23 -27.78% | -0.27 | 0.04 | 13.27% |
| Q1 2020 Q2Q % growth | -0.50 | -0.23 | -0.27 | -119.49% |
| Q4 2019 Q2Q % growth | -0.15 | -0.27 | 0.12 | 44.15% |
| Q3 2019 Q2Q % growth | -0.28 | -0.25 | -0.03 | -11.29% |
| Q2 2019 Q2Q % growth | -0.18 | -0.28 | 0.10 | 35.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 18.928M 108.60% | 17.046M | 1.882M | 11.04% |
| Q1 2025 Q2Q % growth | 17.282M 116.95% | 15.434M | 1.848M | 11.97% |
| Q4 2024 Q2Q % growth | 11.647M 59.26% | 10.741M | 906K | 8.43% |
| Q3 2024 Q2Q % growth | 10.324M 46.90% | 9.889M | 435K | 4.40% |
| Q2 2024 Q2Q % growth | 9.074M -24.36% | 8.976M | 98K | 1.09% |
| Q1 2024 Q2Q % growth | 7.966M 50.19% | 8.16M | -194K | -2.38% |
| Q4 2023 Q2Q % growth | 7.313M -13.96% | 7.854M | -541K | -6.89% |
| Q3 2023 Q2Q % growth | 7.028M 118.26% | 6.384M | 644K | 10.09% |
| Q2 2023 Q2Q % growth | 11.997M 63.00% | 6.639M | 5.358M | 80.70% |
| Q1 2023 Q2Q % growth | 5.304M 143.30% | 4.647M | 657K | 14.14% |
| Q4 2022 Q2Q % growth | 8.5M 39.57% | 9.301M | -801K | -8.61% |
| Q3 2022 Q2Q % growth | 3.22M 312.82% | 3.11M | 110K | 3.54% |
| Q2 2022 Q2Q % growth | 7.36M 139.74% | 7.92M | -560K | -7.07% |
| Q1 2022 Q2Q % growth | 2.18M -81.68% | 7.242M | -5.062M | -69.90% |
| Q4 2021 Q2Q % growth | 6.09M 7,512.50% | 12.768M | -6.678M | -52.30% |
| Q3 2021 Q2Q % growth | 780K 587.50% | 3.102M | -2.322M | -74.85% |
| Q2 2021 Q2Q % growth | 3.07M 15,250.00% | 3.887M | -817K | -21.02% |
| Q1 2021 Q2Q % growth | 11.9M 11,800.00% | 12.295M | -395K | -3.21% |
| Q4 2020 Q2Q % growth | 80K -82.61% | 1.361M | -1.281M | -94.12% |
| Q3 2020 Q2Q % growth | -160K | 1.519M | -1.679M | -110.53% |
| Q2 2020 Q2Q % growth | 20K | 300.217K | -280.217K | -93.34% |
| Q1 2020 Q2Q % growth | 100K -80.00% | 1.545M | -1.445M | -93.53% |
| Q4 2019 Q2Q % growth | 460K | 683.737K | -223.737K | -32.72% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -18.18% | -49.06% | -36.14% | -65.58% |
| Revenue | 1% | -5.01% | 2.06% | 3.53% |